Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Impact of tumour heterogeneity on precision medicine in kidney and bladder cancers

Is genomic classification going to help in RCC?

Date

11 Sep 2017

Session

Impact of tumour heterogeneity on precision medicine in kidney and bladder cancers

Presenters

Laurence Albiges

Authors

L. Albiges

Author affiliations

  • Medical Oncology, Institut Gustave Roussy, 94800 - Villejuif/FR
More

Resources

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.